State of Wisconsin Investment Board’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
PCM
ACM
FCM
BFS
LGP
CS
LCM
NCM
State of Wisconsin Investment Board's BMY.RT Position: Q4 2020 in Review
State of Wisconsin Investment Board sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2020, closing a stake of 727,668 shares — an estimated $1.64M sold.
State of Wisconsin Investment Board first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $3.94M in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.
- State of Wisconsin Investment Board reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q4 2020 after selling out during the quarter.
- State of Wisconsin Investment Board sold 727,668 Bristol-Myers Squibb Company Contingent Value Rights shares in Q4 2020, an estimated $1.64M.
- State of Wisconsin Investment Board first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
- State of Wisconsin Investment Board's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.94M in Q1 2020.
- 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.
Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.